|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Norwegian University of Science and Technology |
| Information provided by: | Norwegian University of Science and Technology |
| ClinicalTrials.gov Identifier: | NCT00281346 |
Purpose
Non-invasive evaluation of patients with stable angina and unstable coronary syndromes with transthoracic Doppler echocardiography to evaluate presence of significant coronary stenoses. Blinded evaluation and comparison with coronary angiography: presence and location of stenoses, and head to head comparison of clinical value and patient classification.
| Condition | Intervention |
|
Stable Angina Pectoris Unstable Angina Pectoris Acute Myocardial Infarction |
Procedure: Doppler echocardiography |
| MedlinePlus related topics: | Angina Heart Attack |
| Study Type: | Interventional |
| Study Design: | Diagnostic, Non-Randomized, Double Blind (Subject, Caregiver, Outcomes Assessor), Uncontrolled, Single Group Assignment, Efficacy Study |
| Official Title: | Non-Invasive Evaluation of Coronary Pathology by Transthoracic Doppler Echocardiography. A Comparative Study to Coronary Angiography. |
| Estimated Enrollment: | 100 |
| Study Start Date: | December 2005 |
| Estimated Study Completion Date: | June 2007 |
| Estimated Primary Completion Date: | June 2007 (Final data collection date for primary outcome measure) |
Transthoracic Doppler echocardiographic evaluation with extensive evaluation of coronary stenoses in all 3 main branches using colour flow, pulsed Doppler and Coronary flow velocity reserve (CFVR)after pharmacologic stress with adenosin in the area of LAD and RDP. Blinded evaluation of Doppler results and coronary angiography regarding the other examination modality. Coronary angiography diagnostic "gold standard". Only stable and unstable patients otherwise scheduled for angiography on clinical reasons will be examined and included in the study.
Added January 2007 after ethics committee approval: comparison of CFVR with invasive fractional flow reserve (FFR) in selected subset of patients.
Eligibility
| Ages Eligible for Study: | 18 Years to 90 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Norway | |||||
| Ålesund Hospital HF | |||||
| Ålesund, Norway, N-6026 | |||||
| Norwegian University of Science and Technology |
| Study Chair: | Torstein L Hole, MD, PhD | Norwegian University of Science and Technology |
| Principal Investigator: | Johnny Å Vegsundvåg, MD | Unaffiliated |
| Study Chair: | Rune Wiseth, MD, PhD | Norwegian University of Science and Technology |
More Information
| Responsible Party: | Norwegian University of Science and Technology ( Torstein Hole ) |
| Study ID Numbers: | 29 FU-71-05 |
| First Received: | January 23, 2006 |
| Last Updated: | April 18, 2008 |
| ClinicalTrials.gov Identifier: | NCT00281346 |
| Health Authority: | Norway: Norwegian Social Science Data Services |
|
|
|
|